Search for: "APOTEX CORP." Results 161 - 180 of 333
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Mar 2012, 1:00 am by Courtenay Brinckerhoff
Apotex Corp., the Federal Circuit held that the district court had jurisdiction over AstraZeneca’s ANDA complaint, but also held that the complaint should be dismissed for failing to state a viable claim for relief because the ANDAs included Section viii... [read post]
4 Mar 2012, 9:02 am by Schachtman
Next year, the Supreme Court’s Daubert decision will turn 20. [read post]
10 Feb 2012, 12:39 pm
Orange County - Apotex Corp., Canada's largest pharmaceutical manufacturer, has paid Bristol-Myers Squibb Co. and Sanofi SA nearly $445 million in damages to end a decade-long patent infringement lawsuit over Apotex' improper sales of its generic version of Plavix. [read post]
10 Feb 2012, 10:56 am by Courtney Minick
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
10 Feb 2012, 10:56 am by Courtney Minick
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
9 Feb 2012, 3:43 pm by Patent Docs
Apotex Corp., the Court held that alleging infringement under 35 U.S.C. [read post]
8 Dec 2011, 9:50 am
., Ltd.) of Tokyo, Japan, after a bench trial on the plaintiff's patent infringement claims against Apotex, Inc., of Ontario, Canada and Apotex Corp. [read post]
4 Dec 2011, 8:52 pm by Patent Docs
• Defendants: Apotex, Inc.; Apotex Corp. [read post]
9 Nov 2011, 9:59 pm by Patent Docs
., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and counterclaims by Defendants-Appellants Apotex Inc. and Apotex Corp. [read post]
13 Oct 2011, 7:45 pm
Apotex, Inc., 470 F.3d 1368, 1374 (Fed. [read post]